Company page
Innocan Pharma Corporation
Innocan Pharma Corporation, trading under the ticker INNO, is a public company based in Canada. The company has a market capitalization of approximately CAD 10 million. Innocan focuses on developing innovative pharmaceutical products, particularly in the field of cannabinoid-based therapies.
- Ticker
- INNO:CSE
- Asset type
- Stock
- Market cap
- $10.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- CSE
- Currency
- CAD